Price History
Feb 9, 2026 — May 15, 2026Investment Snapshot
- Trading 1,005% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- Strong ROE of 232.0% with 10.5% net margin
- Revenue growing at 35% annually
SANUWAVE Health, Inc. - Common Stock (SNWV) is a Healthcare company operating in Medical Devices, listed on the NASDAQ , with a market capitalisation of $147 million . Key value metrics: P/E ratio 34.4, P/B ratio 79.86, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
SANUWAVE Health, Inc. - Common Stock — Fundamental Analysis Summary
SANUWAVE Health, Inc. - Common Stock (SNWV) is currently trading 1,005% above its Graham Number of $1.54, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 34.4x.
On financial health, SNWV shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 232.0% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 11.16.
StockPik's composite Value Score for SNWV is 51/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SNWV reports a high gross margin of 78.1% (sector average: 40.1%) and a modest operating margin of 7.9%.
SNWV shows revenue growing at 35% year-over-year, with earnings growing at 138%.